Bank Of New York Mellon Corp Corbus Pharmaceuticals Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $5.46 $3,526 - $175,053	32,061 New	32,061 $3,000
Q3 2021 Nov 12, 2021	SELL	$1.01 - $1.82 $164,560 - $296,534	-162,931 Reduced 82.61%	34,301 $35,000
Q2 2021 Aug 11, 2021	SELL	$1.39 - $2.21 $97,134 - $154,437	-69,881 Reduced 26.16%	197,232 $360,000
Q1 2021 May 13, 2021	BUY	$1.27 - $3.42 $51,676 - $139,159	40,690 Added 17.97%	267,113 $526,000
Q4 2020 Feb 09, 2021	SELL	$0.94 - $1.89 $43,575 - $87,614	-46,357 Reduced 16.99%	226,423 $283,000
Q3 2020 Nov 12, 2020	BUY	$1.5 - $9.38 $3,243 - $20,279	2,162 Added 0.8%	272,780 $491,000
Q2 2020 Aug 12, 2020	BUY	$4.79 - $8.39 $252,442 - $442,169	52,702 Added 24.18%	270,618 $2.27 Million
Q1 2020 May 06, 2020	BUY	$3.44 - $7.21 $64,407 - $134,992	18,723 Added 9.4%	217,916 $1.14 Million
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $17,267 - $22,701	4,025 Added 2.06%	199,193 $1.09 Million
Q3 2019 Nov 07, 2019	SELL	$4.87 - $7.08 $72,884 - $105,959	-14,966 Reduced 7.12%	195,168 $950,000
Q2 2019 Aug 12, 2019	BUY	$6.6 - $7.8 $27,159 - $32,097	4,115 Added 2.0%	210,134 $1.46 Million
Q1 2019 May 14, 2019	BUY	$5.76 - $8.95 $67,075 - $104,222	11,645 Added 5.99%	206,019 $1.43 Million
Q4 2018 Feb 11, 2019	BUY	$5.26 - $7.97 $85,764 - $129,950	16,305 Added 9.16%	194,374 $1.14 Million
Q3 2018 Nov 09, 2018	SELL	$4.65 - $7.95 $44,760 - $76,526	-9,626 Reduced 5.13%	178,069 $0
Q2 2018 Aug 06, 2018	SELL	$5.05 - $6.8 $10,408 - $14,014	-2,061 Reduced 1.09%	187,695 $948,000
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $996 - $1,646	178 Added 0.09%	189,756 $1.16 Million
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $1.25 Million - $1.47 Million	189,578	189,578 $1.35 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account